<svg xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" version="1.1" class="marks" width="188" height="413" viewBox="0 0 188 413"><rect width="188" height="413" fill="white"/><g fill="none" stroke-miterlimit="10" transform="translate(43,10)"><g class="mark-group role-frame root" role="graphics-object" aria-roledescription="group mark container"><g transform="translate(0,0)"><path class="background" aria-hidden="true" d="M0.5,0.5h140v200h-140Z" stroke="#ddd"/><g><g class="mark-group role-axis" aria-hidden="true"><g transform="translate(0.5,0.5)"><path class="background" aria-hidden="true" d="M0,0h0v0h0Z" pointer-events="none"/><g><g class="mark-rule role-axis-grid" pointer-events="none"><line transform="translate(0,200)" x2="140" y2="0" stroke="#ddd" stroke-width="1" opacity="1"/><line transform="translate(0,150)" x2="140" y2="0" stroke="#ddd" stroke-width="1" opacity="1"/><line transform="translate(0,100)" x2="140" y2="0" stroke="#ddd" stroke-width="1" opacity="1"/><line transform="translate(0,50)" x2="140" y2="0" stroke="#ddd" stroke-width="1" opacity="1"/><line transform="translate(0,0)" x2="140" y2="0" stroke="#ddd" stroke-width="1" opacity="1"/></g></g><path class="foreground" aria-hidden="true" d="" pointer-events="none" display="none"/></g></g><g class="mark-group role-axis" role="graphics-symbol" aria-roledescription="axis" aria-label="X-axis titled 'Entity' for a discrete scale with 7 values: Health insurance, Pharmaceutical, Researchers who study infectious diseases, State and local elected, companies, infectious diseases, officials"><g transform="translate(0.5,200.5)"><path class="background" aria-hidden="true" d="M0,0h0v0h0Z" pointer-events="none"/><g><g class="mark-rule role-axis-tick" pointer-events="none"><line transform="translate(10,0)" x2="0" y2="5" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(30,0)" x2="0" y2="5" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(50,0)" x2="0" y2="5" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(70,0)" x2="0" y2="5" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(90,0)" x2="0" y2="5" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(110,0)" x2="0" y2="5" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(130,0)" x2="0" y2="5" stroke="#888" stroke-width="1" opacity="1"/></g><g class="mark-text role-axis-label" pointer-events="none"><text text-anchor="end" transform="translate(9.5,7) rotate(270) translate(0,3)" font-family="sans-serif" font-size="10px" fill="#000" opacity="1">Health insurance</text><text text-anchor="end" transform="translate(29.5,7) rotate(270) translate(0,3)" font-family="sans-serif" font-size="10px" fill="#000" opacity="1">Pharmaceutical</text><text text-anchor="end" transform="translate(49.5,7) rotate(270) translate(0,3)" font-family="sans-serif" font-size="10px" fill="#000" opacity="1">Researchers who study…</text><text text-anchor="end" transform="translate(69.5,7) rotate(270) translate(0,3)" font-family="sans-serif" font-size="10px" fill="#000" opacity="1">State and local elect…</text><text text-anchor="end" transform="translate(89.5,7) rotate(270) translate(0,3)" font-family="sans-serif" font-size="10px" fill="#000" opacity="1">companies</text><text text-anchor="end" transform="translate(109.5,7) rotate(270) translate(0,3)" font-family="sans-serif" font-size="10px" fill="#000" opacity="1">infectious diseases</text><text text-anchor="end" transform="translate(129.5,7) rotate(270) translate(0,3)" font-family="sans-serif" font-size="10px" fill="#000" opacity="1">officials</text></g><g class="mark-rule role-axis-domain" pointer-events="none"><line transform="translate(0,0)" x2="140" y2="0" stroke="#888" stroke-width="1" opacity="1"/></g><g class="mark-text role-axis-title" pointer-events="none"><text text-anchor="middle" transform="translate(70,196)" font-family="sans-serif" font-size="11px" font-weight="bold" fill="#000" opacity="1">Entity</text></g></g><path class="foreground" aria-hidden="true" d="" pointer-events="none" display="none"/></g></g><g class="mark-group role-axis" role="graphics-symbol" aria-roledescription="axis" aria-label="Y-axis titled 'Acceptable' for a linear scale with values from 0 to 80"><g transform="translate(0.5,0.5)"><path class="background" aria-hidden="true" d="M0,0h0v0h0Z" pointer-events="none"/><g><g class="mark-rule role-axis-tick" pointer-events="none"><line transform="translate(0,200)" x2="-5" y2="0" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(0,150)" x2="-5" y2="0" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(0,100)" x2="-5" y2="0" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(0,50)" x2="-5" y2="0" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(0,0)" x2="-5" y2="0" stroke="#888" stroke-width="1" opacity="1"/></g><g class="mark-text role-axis-label" pointer-events="none"><text text-anchor="end" transform="translate(-7,203)" font-family="sans-serif" font-size="10px" fill="#000" opacity="1">0</text><text text-anchor="end" transform="translate(-7,153)" font-family="sans-serif" font-size="10px" fill="#000" opacity="1">20</text><text text-anchor="end" transform="translate(-7,103)" font-family="sans-serif" font-size="10px" fill="#000" opacity="1">40</text><text text-anchor="end" transform="translate(-7,53)" font-family="sans-serif" font-size="10px" fill="#000" opacity="1">60</text><text text-anchor="end" transform="translate(-7,3)" font-family="sans-serif" font-size="10px" fill="#000" opacity="1">80</text></g><g class="mark-rule role-axis-domain" pointer-events="none"><line transform="translate(0,200)" x2="0" y2="-200" stroke="#888" stroke-width="1" opacity="1"/></g><g class="mark-text role-axis-title" pointer-events="none"><text text-anchor="middle" transform="translate(-27,100) rotate(-90) translate(0,-2)" font-family="sans-serif" font-size="11px" font-weight="bold" fill="#000" opacity="1">Acceptable</text></g></g><path class="foreground" aria-hidden="true" d="" pointer-events="none" display="none"/></g></g><g class="mark-rect role-mark marks" role="graphics-object" aria-roledescription="rect mark container"><path aria-label="Entity: infectious diseases; Acceptable: 75" role="graphics-symbol" aria-roledescription="bar" d="M101,12.5h18v187.5h-18Z" fill="#4c78a8"/><path aria-label="Entity: Researchers who study infectious diseases; Acceptable: 75" role="graphics-symbol" aria-roledescription="bar" d="M41,12.5h18v187.5h-18Z" fill="#4c78a8"/><path aria-label="Entity: companies; Acceptable: 40" role="graphics-symbol" aria-roledescription="bar" d="M81,100h18v100h-18Z" fill="#4c78a8"/><path aria-label="Entity: Pharmaceutical; Acceptable: 40" role="graphics-symbol" aria-roledescription="bar" d="M21,100h18v100h-18Z" fill="#4c78a8"/><path aria-label="Entity: Health insurance; Acceptable: 40" role="graphics-symbol" aria-roledescription="bar" d="M1,100h18v100h-18Z" fill="#4c78a8"/><path aria-label="Entity: officials; Acceptable: 37" role="graphics-symbol" aria-roledescription="bar" d="M121,107.5h18v92.5h-18Z" fill="#4c78a8"/><path aria-label="Entity: State and local elected; Acceptable: 37" role="graphics-symbol" aria-roledescription="bar" d="M61,107.5h18v92.5h-18Z" fill="#4c78a8"/></g></g><path class="foreground" aria-hidden="true" d="" display="none"/></g></g></g></svg>